Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE.
Bollard CM, et al. Among authors: carrum g.
J Exp Med. 2004 Dec 20;200(12):1623-33. doi: 10.1084/jem.20040890.
J Exp Med. 2004.
PMID: 15611290
Free PMC article.